Page 17 - Read Online

Page 12 of 13 Zhao et al. Microbiome Res Rep. 2025;4:28 https://dx.doi.org/10.20517/mrr.2025.12

19. Liu X, Li J, Shi M, et al. Melatonin improves cholestatic liver disease via the gut-liver axis. J Pineal Res. 2024;76:e12929. DOI
PubMed
20. Wan Y, Yuan J, Li J, et al. Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and
associated with related gut microbiota: a 6-month randomized controlled-feeding trial. Clin Nutr. 2020;39:395-404. DOI PubMed
21. Jiao N, Baker SS, Chapa-Rodriguez A, et al. Suppressed hepatic bile acid signalling despite elevated production of primary and
secondary bile acids in NAFLD. Gut. 2018;67:1881-91. DOI PubMed
22. He X, Gao X, Hong Y, et al. High fat diet and high sucrose intake divergently induce dysregulation of glucose homeostasis through
distinct gut microbiota-derived bile acid metabolism in mice. J Agric Food Chem. 2024;72:230-44. DOI PubMed
23. Parasar B, Zhou H, Xiao X, Shi Q, Brito IL, Chang PV. Chemoproteomic profiling of gut microbiota-associated bile salt hydrolase
activity. ACS Cent Sci. 2019;5:867-73. DOI PubMed PMC
24. Khodakivskyi PV, Lauber CL, Yevtodiyenko A, et al. Noninvasive imaging and quantification of bile salt hydrolase activity: from
bacteria to humans. Sci Adv. 2021;7:eaaz9857. DOI PubMed PMC
25. Yu J, Zhang H, Chen L, Ruan Y, Chen Y, Liu Q. Disease-associated gut microbiota reduces the profile of secondary bile acids in
pediatric nonalcoholic fatty liver disease. Front Cell Infect Microbiol. 2021;11:698852. DOI PubMed PMC
26. Li Y, Wang H, He X, et al. Zhi-Kang-Yin formula attenuates high-fat diet-induced metabolic disorders through modulating gut
microbiota-bile acids axis in mice. Chin Med. 2024;19:145. DOI PubMed PMC
27. Jia W, Rajani C, Zheng X, Jia W. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling
mechanism. J Mol Cell Biol. 2021;13:460-2. DOI PubMed PMC
28. Zhao WW, Xiao M, Wu X, et al. Ilexsaponin A Ameliorates diet-induced nonalcoholic fatty liver disease by regulating bile acid
1
metabolism in mice. Front Pharmacol. 2021;12:771976. DOI PubMed PMC
29. Xu H, Yuan M, Niu K, et al. Involvement of bile acid metabolism and gut microbiota in the amelioration of experimental metabolism-
associated fatty liver disease by nobiletin. Molecules. 2024;29:976. DOI PubMed PMC
30. Li X, Zhao W, Xiao M, et al. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut
microbiota and bile acid metabolism in mice. J Ethnopharmacol. 2022;294:115333. DOI PubMed
31. Li DK, Chaudhari SN, Lee Y, et al. Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability
and liver injury. Sci Adv. 2022;8:eabo2794. DOI PubMed PMC
32. Li ZM, Kong CY, Mao YQ, et al. Host ALDH2 deficiency aggravates nonalcoholic steatohepatitis through gut-liver axis. Pharmacol
Res. 2023;196:106902. DOI PubMed
33. Gao X, Lin X, Xin Y, et al. Dietary cholesterol drives the development of nonalcoholic steatohepatitis by altering gut microbiota
mediated bile acid metabolism in high-fat diet fed mice. J Nutr Biochem. 2023;117:109347. DOI PubMed
34. Zhuge A, Li S, Yuan Y, et al. Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards
nonalcoholic steatohepatitis in mice. Redox Biol. 2023;59:102582. DOI PubMed PMC
35. Shen B, Zhou C, Gu T, et al. Kuhuang alleviates liver fibrosis by modulating gut microbiota-mediated hepatic IFN signaling and bile
acid synthesis. Front Pharmacol. 2022;13:1080226. DOI PubMed PMC
36. Takimoto Y, Chu PS, Nakamoto N, et al. Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis.
iScience. 2023;26:106220. DOI PubMed PMC
37. Liu Y, Chen K, Li F, et al. Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis
and enhancing bile acid excretion in mice. Hepatology. 2020;71:2050-66. DOI PubMed PMC
38. Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513:59-64. DOI PubMed
39. Kobyliak N, Abenavoli L, Falalyeyeva T, et al. Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a
randomized clinical study. Minerva Med. 2018;109:418-28. DOI PubMed
40. Fogelson KA, Dorrestein PC, Zarrinpar A, Knight R. The gut microbial bile acid modulation and its relevance to digestive health and
diseases. Gastroenterology. 2023;164:1069-85. DOI PubMed PMC
41. Chen ML, Yi L, Zhang Y, et al. Resveratrol attenuates trimethylamine- N -oxide (TMAO)-induced atherosclerosis by regulating
TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. mBio. 2016;7:e02210-15. DOI PubMed PMC
42. Pontes KSDS, Guedes MR, Cunha MRD, et al. Effects of probiotics on body adiposity and cardiovascular risk markers in individuals
with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2021;40:4915-31. DOI
PubMed
43. Agolino G, Pino A, Vaccalluzzo A, et al. Bile salt hydrolase: the complexity behind its mechanism in relation to lowering-cholesterol
lactobacilli probiotics. J Funct Foods. 2024; 120:106357. DOI
44. Kumar R, Grover S, Batish VK. Bile salt hydrolase (Bsh) activity screening of lactobacilli: in vitro selection of indigenous
lactobacillus strains with potential bile salt hydrolysing and cholesterol-lowering ability. Probiotics Antimicro Prot. 2012;4:162-72.
DOI PubMed
45. Yang Y, Liu Y, Zhou S, Huang L, Chen Y, Huan H. Bile salt hydrolase can improve Lactobacillus plantarum survival in
gastrointestinal tract by enhancing their adhesion ability. FEMS Microbiol Lett. 2019;366:fnz100. DOI PubMed
46. Li F, Jiang C, Krausz KW, et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased
obesity. Nat Commun. 2013;4:2384. DOI PubMed PMC
47. Huang F, Zheng X, Ma X, et al. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and
bile acid metabolism. Nat Commun. 2019;10:4971. DOI PubMed PMC